Toshihiro Matsuo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshihiro Matsuo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Katsuhisa Kawanami
Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Aichi, Japan
3 shared publications - Atsuhiko Hirasawa
Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Aichi, Japan
2 shared publications - Masataka Deie
Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Aichi, Japan
2 shared publications - Mitsuhiro Kamiya
Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Aichi, Japan
2 shared publications - Norimitsu Wakao
Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Aichi, Japan
2 shared publications - Emiko Takahashi
Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan
1 shared publication
Latest Publications
- 1 March 2020
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 25 (2) , 349-353
Two cases of pelvic sarcoma in the acetabulum with >10-year follow-ups after carbon ion radiotherapy
- 1 March 2020
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 25 (2) , 349-353
Two cases of pelvic sarcoma in the acetabulum with >10-year follow-ups after carbon ion radiotherapy
- 7 May 2018
- Published by Elsevier in Journal of Orthopaedics
- Vol. 15 (2) , 606-609
Bizarre parosteal osteochondromatous proliferation of the femur: A case report
- 7 May 2018
- Published by Elsevier in Journal of Orthopaedics
- Vol. 15 (2) , 606-609
Bizarre parosteal osteochondromatous proliferation of the femur: A case report
- Open Access
- 23 June 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (3) , 3071-3076
Inhibitory effects of low-intensity pulsed ultrasound sonication on the proliferation of osteosarcoma cells
To date, there is limited data on the biological effects of low-intensity pulsed ultrasound (LIPUS) on primary malignant bone tumors. The purpose of the present study was to investigate the antitumor effects of LIPUS on osteosarcoma cells. The effects of LIPUS on cell viability, induction of apoptosis, mitochondrial membrane potential and intracellular signaling molecules in the LM8 osteosarcoma cell line were investigated. LIPUS inhibited cell viability (P=0.0022) and mitochondrial membrane potential (P=0.0019) in LM8 cells. Flow cytometry analysis and terminal deoxynucleotidyl transferase dUTP nick end labeling staining revealed significantly higher numbers of apoptotic (P<0.0001) and necrotic cells (P=0.0091) compared with cells without treatment. LIPUS treatment significantly increased phosphorylated Akt (P<0.0001) and IκBα (P=0.0001) levels, and reduced phosphorylated mitogen-activated protein kinase 7 (P<0.0001) and phosphorylated checkpoint kinase 1 (P=0.0008) levels. These results suggest that LIPUS is a non-invasive adjuvant therapy that is able to inhibit cellular proliferation in osteosarcoma cells.
- 23 June 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (3) , 3071-3076
Open AccessInhibitory effects of low-intensity pulsed ultrasound sonication on the proliferation of osteosarcoma cells
To date, there is limited data on the biological effects of low-intensity pulsed ultrasound (LIPUS) on primary malignant bone tumors. The purpose of the present study was to investigate the antitumor effects of LIPUS on osteosarcoma cells. The effects of LIPUS on cell viability, induction of apoptosis, mitochondrial membrane potential and intracellular signaling molecules in the LM8 osteosarcoma cell line were investigated. LIPUS inhibited cell viability (P=0.0022) and mitochondrial membrane potential (P=0.0019) in LM8 cells. Flow cytometry analysis and terminal deoxynucleotidyl transferase dUTP nick end labeling staining revealed significantly higher numbers of apoptotic (P<0.0001) and necrotic cells (P=0.0091) compared with cells without treatment. LIPUS treatment significantly increased phosphorylated Akt (P<0.0001) and IκBα (P=0.0001) levels, and reduced phosphorylated mitogen-activated protein kinase 7 (P<0.0001) and phosphorylated checkpoint kinase 1 (P=0.0008) levels. These results suggest that LIPUS is a non-invasive adjuvant therapy that is able to inhibit cellular proliferation in osteosarcoma cells.
- 2 July 2016
- Published by Elsevier in Journal of Orthopaedics
- Vol. 13 (4) , 313-315
An extremely rare case of a glomus tumor in the popliteal fossa
- 2 July 2016
- Published by Elsevier in Journal of Orthopaedics
- Vol. 13 (4) , 313-315
An extremely rare case of a glomus tumor in the popliteal fossa